[Form 4] Enovix Corporation Warrant Insider Trading Activity

Rhea-AI Filing Summary

Form 4 summary: Reporting person Bernard Gutmann (Director) reported a transaction for Enovix Corp (ticker shown as ENVX) dated 08/06/2025.

• Transaction: Exercise of publicly-traded warrants resulting in 5,096 shares issued at an exercise price of $8.75 per share.
• Post-transaction beneficial ownership: 69,959 shares (this total includes 29,190 RSUs issuable upon settlement).
• Filing details: Form filed by one reporting person; form signed by Attorney-in-Fact Arthi Chakravarthy on 08/07/2025.

Insights

Securities Analyst

TL;DR: Insider exercised warrants for 5,096 shares at $8.75; beneficial ownership reported at 69,959 shares.

The filing documents a warrant exercise on 08/06/2025 that issued 5,096 common shares at an exercise price of $8.75 per share. The reported beneficial ownership following the transaction is 69,959 shares, which the filer discloses includes 29,190 RSUs issuable upon settlement. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on 08/07/2025. From a securities-transaction disclosure perspective, this is a routine insider exercise and recordation of resulting beneficial ownership; the filing contains no earnings or covenant information to assess broader financial impact.

Corporate Governance Expert

TL;DR: Routine Form 4 reporting of a director's warrant exercise and RSU holdings; no additional governance changes disclosed.

The document identifies Bernard Gutmann as the reporting director and discloses the mechanics of the issuance: exercise of publicly-traded warrants at $8.75 per share leading to 5,096 shares issued. It also discloses 29,190 RSUs included in the reported beneficial ownership of 69,959 shares. The filing does not report officer changes, related-party transactions beyond the exercise, or amendments to compensation arrangements. As filed, the disclosure meets Section 16 reporting requirements but does not on its face indicate corporate-governance actions or material changes to board composition or compensation plans.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GUTMANN BERNARD

(Last) (First) (Middle)

C/O ENOVIX CORPORATION

3501 W WARREN AVENUE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2025		X		5,096(1)	A	$8.75	69,959(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares issued to the Reporting Person upon the exercise of publicly-traded warrants ("Warrants"). Each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance to the warrant agreement.

2. Includes 29,190 shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Remarks:

	/s/ Arthi Chakravarthy, Attorney-in-Fact for Bernard Gutmann	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Bernard Gutmann report on the Form 4 for Enovix (ENVX/ENVXW)?

The Form 4 reports the exercise of publicly-traded warrants on 08/06/2025, resulting in issuance of 5,096 common shares at an exercise price of $8.75 per share.

How many shares does Bernard Gutmann beneficially own after the reported transaction?

The filing reports 69,959 shares beneficially owned following the transaction, which includes 29,190 RSUs issuable upon settlement.

What is the exercise price and date of the warrants exercised?

The warrants were exercised at an exercise price of $8.75 per share with a transaction date of 08/06/2025.

Who signed the Form 4 and when was it signed?

The Form 4 is signed by /s/ Arthi Chakravarthy, Attorney-in-Fact for Bernard Gutmann and dated 08/07/2025.

Was the Form 4 filed by one reporting person or more than one?

The form indicates it was filed by one reporting person (the box for a single reporting person is checked).